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Glucose-responsive polymer nanogels that can undergo a reversible and rapid volume phase transition in
response to the fluctuation in blood glucose concentration have the potential to regulate the delivery of
insulin mimicking pancreatic activity. We report here such a glucose-responsive polymer nanogel, which
is made of concanavalin A (ConA) interpenetrated in a chemically crosslinked network of poly(N-
isopropylacrylamide) (poly(NIPAM)). The introduction of ConA, a plant lectin protein, into the
poly(NIPAM) network makes the newly developed semi-interpenetrating-structured nanogels responsive
to glucose over a glucose concentration range of 0–20 mM at a physiological pH of 7.4. While the
nanogels can swell and become stable shortly (<1 s) after adding glucose over a concentration range of
50.0 mM to 20.0 mM, the changes in the average hydrodynamic radius and the size distribution of the
nanogels can be fully reversible within the experimental error even after ten cycles of adding/removing
glucose. The association rate constant is determined to be ca. 1.8 mM1 s1, and the dissociation rate
constant is ca. 7.5 s1, indicating a fast reversible time response to the glucose concentration change of
the nanogels. Moreover, in vitro insulin release can be modulated in a pulsatile profile in response to
glucose concentrations.Introduction
Polymer gels with a three-dimensional crosslinked network
structure are attractive as carriers due to their unique physical
properties common to living tissues, including a so and
rubbery consistency, and low interfacial tension with water or
biological uids.1–13 Of particular interest are those stimuli-
responsive “smart polymer gels” that can undergo a reversible
and rapid volume phase transition in response to external
stimuli, such as temperature, pH, light, and even electrical or
magnetic eld.14–20 If a stimuli-responsive gel is sensitive to the
uctuation in the concentration of a specic biomolecule, it can
mimic biofeedback systems, thus providing both a functional
and structural basis for self-regulated materials and systems for
prospective biomedical applications.21–25
Polymer gels with glucose-responsive features are becoming
more and more important for treatment of diseases such as
diabetes mellitus that are associated with the disruptions in the
homeostasis of glucose concentrations in blood.22–25 Diabetes
mellitus is not an infectious disease, but its rapidly increasingof Solid Surfaces, The Key Laboratory for
Department of Chemistry, College of
en University, Xiamen 361005, Fujian,
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ESI) available: FTIR and DLS data. Seeworldwide prevalence has been recognized as a pandemic, and
thus diabetes mellitus poses a serious global health threat
much like epidemics of truly infectious diseases.26 Despite the
necessity for the continuous and accurate glucose control in the
administration of type 1 diabetic patients and advanced type 2
diabetic patients, the current palliative treatment requires
frequent self-monitoring of glucose concentrations and subse-
quent self-injection of insulin to achieve normoglycemia, also
known as open-loop insulin delivery.26 Although the benets are
already apparent from the use of such self-administration, it not
only impinges on the quality of life of the patient but also fails
to precisely control the dose of insulin. It is reported that only
approximately 20% of insulin reaches the liver (which is the
primary site of action according to normal physiology) following
the insulin injection.27 The lack of tight control of glucose
concentrations accounts for many chronic complications of
diabetes such as limb amputation, blindness, and kidney
failure. Excess insulin in the body can lead to hypoglycemia,
insulin resistance, and other unwanted side effects, resulting in
risks of unconsciousness, brain damage, or death.28,29 In addi-
tion, there are challenges to accurate monitoring of daily uc-
tuations in glucose concentration in order to adjust the dose
and dosing time of insulin. In this respect, earlier studies have
been focused on developing closed-loop insulin delivery
systems by using glucose-responsive bulky gels, which can
integrate both a glucose-recognition moiety (e.g., glucose


































View Article Onlinestorage/release matrix within one material.22–25,30–33 While the
incorporation of a glucose-recognition moiety into the polymer
gels can readily enable the polymer gels to demonstrate a
volume phase transition in response to a glucose concentration
change in the surrounding medium, the resulting changes in
the mesh size of the polymer gels can modulate the release of
insulin molecules that are physically imbibed in the gels.
However, those bulky polymer gels as carriers need a long time
to reach swelling/collapsing equilibrium.
Theoretically, the characteristic time period that describes
the volume change of the polymer gels is approximately
proportional to the square of the characteristic length of the
gels.34 Thus, as an effective method among others to address the
slow-time-response issue of the examples based on bulky poly-
mer gels, our group and other groups have actively explored the
feasibility of downsizing the glucose-responsive bulky gels into
submicron and even nanogels since 2006.35–53 Most of those
glucose-responsive micro-/nanogels use PBA as the glucose-
recognition moiety. PBA covalently binds cis-diols to form ther-
modynamically more favorable 5-membered ring cyclic esters.54
While second scale swelling processes have indeed been deter-
mined for an individual PBA-based micro-/nanogel at an
increasing glucose concentration, it usually takes a long time for
the PBA-based micro-/nanogel to reach the deswelling equilib-
rium under the decreasing glucose concentration conditions,
making it still difficult to deliver the demanded amount of
insulin in response to a change in blood glucose concentration
(in particular, a sharp increase in blood glucose concentration
aer a meal).54 Clearly, in order to use the glucose-responsive
polymer gels as carriers in a living body ultimately, it is crucial to
exploit new micro-/nanogels of reversible and rapid trigger
modes as close to physiological conditions as possible.
In this work, we aim to develop a new class of glucose-
responsive nanogels that can undergo a reversible and rapid
volume phase transition in response to the disruptions in the
homeostasis of glucose concentration. As schematically depic-
ted in Scheme 1, this newly developed nanogel (denoted as
ConA@poly(NIPAM)) is comprised of concanavalin A (ConA), as
the glucose recognition moiety,30,54 which is interpenetrated in a
chemically crosslinked network of poly(N-isopropylacrylamide)
(poly(NIPAM)). ConA is a plant lectin protein that is extracted
from Jack beans.55 The ConA tetramer consists of two dimers
and has four binding sites for non-reducing D-glucose,
D-mannose, and polysaccharides, among which the reactivity ofScheme 1 Schematic illustration of the synthesis of the glucose-
responsive nanogels based on ConA, and the chemical structures of
the key components.
This journal is © The Royal Society of Chemistry 2014D-glucose and D-mannose with ConA is stronger than that of
other compounds with ConA. Such a specic structure of ConA
is capable of inducing affinity gelation of polysaccharides or
other polymers that contain glucose/mannose moieties,
whereas free glucose can seize the specic binding sites of the
ConA–polymer complex, leading to the dissociation of the
complex and thus forming glucose-responsive systems. This
responsive principle has been employed in the design of ConA-
based glucose-responsive polymer gels for insulin delivery, ever
since the rst example reported in 1979.22–25,30 Herein, we show
an alternative principle that the glucose-induced conforma-
tional change of the ConA interpenetrated in the polymer
network can be used to trigger a volume phase transition of the
presented ConA@poly(NIPAM) nanogel particle. More impor-
tantly, unlike the ConA–polymer complex gels reported previ-
ously that would suffer from poor stability because the unbound
ConA tends to irreversibly aggregate,54 the presented nanogels
possess good stability, setting a stage for a reversibly and rapidly
glucose-responsive volume change. In addition, we show that
these nanogels can modulate the in vitro delivery of pre-loaded
insulin as a function of medium glucose concentration.Experimental
Materials
The lyophilized human recombinant insulin (C257H338N65O77S6,
5807.69 daltons) was purchased from Tonghua Dongbao Phar-
maceutical Co., and other chemicals were purchased from
Aldrich. N-Isopropylacrylamide (NIPAM) was recrystallized from
a hexane–acetone (1 : 1 volume ratio) mixture and dried in a
vacuum. Concanavalin A (ConA), N,N0-methylenebisacrylamide
(MBAAm), sodium dodecyl sulfate (SDS), ammonium persulfate
(APS),N,N,N0,N0-tetramethylenediamine (TEMED), dextran (Mr
6000), dextran (Mr  40 000), dextran (Mr  100 000), ribonu-
clease B (RNase B) from bovine pancreas (13 700 daltons), D(+)-
glucose, D(+)-mannose, D()-fructose, D(+)-galactose, and insulin
were used as received without further purication. The water
used in all experiments was of Millipore Milli-Q grade.Synthesis of the ConA@poly(NIPAM) nanogels
The ConA@poly(NIPAM) nanogels were prepared by free radical
precipitation copolymerization of NIPAM and MBAAm using
APS/TEMED as an initiating system in the presence of ConA. A
mixture of NIPAM (1.200 g), ConA (0.036 g), MBAAm (0.075 g),
SDS (0.050 g), and water (95 mL) was poured into a 250 mL
three-neck round-bottom ask equipped with a stirrer, a
nitrogen gas inlet, and a condenser. The mixture was heated to
40.0 C under a N2 purge. Aer 30 min, APS (5 mL, 1.491 M) and
TEMED (10 mL, 0.2 wt%) were added one by one at 10 min
intervals to initiate the polymerization. The reaction was
allowed to proceed for 5 h. The product was puried by
centrifugation (Thermo Electron Co. SORVALL® RC-6 PLUS
superspeed centrifuge; the same below), decantation, and then
washed with water. The resulting ConA@poly(NIPAM) nanogels
were further puried by 3 days of dialysis (Spectra/Por®


































View Article Onlinedaltons; the same below) against very frequently changed water
at room temperature (22 C).
Dynamic laser light scattering (DLS) measurements
DLS was performed on a 90Plus multi angle particle sizing
analyzer equipped with a BI-9000AT digital autocorrelator
(Brookhaven Instruments, Inc.) to measure the average hydro-
dynamic radius hRhi and the size distribution. A He–Ne laser
(35 mW, 659 nm) was used as the light source. All nanogel
dispersions were passed through Millipore Millex-HV lters
with a pore size of 0.80 mm to remove dust before DLS
measurements. In DLS, the Laplace inversion (here the CONTIN
method was used) of each measured intensity–intensity time
correlation function in a dilute dispersion can lead to a line-
width distribution G(G). For a purely diffusive relaxation, G is
related to the translational diffusion coefficient D by
(G/q2)C/0,q/0 ¼ D, so that G(G) can be converted to a trans-
lational diffusion coefficient distribution and hRhi distribution
by using the Stokes–Einstein equation, hRhi ¼ (kBT/6ph)/D,
where kB, T, and h are the Boltzmann constant, the absolute
temperature, and the solvent viscosity, respectively.56 All DLS
measurements were made at a scattering angle q ¼ 90.
Response kinetics measurements
The response kinetics measurements were conducted on a
Bio-Logic SFM300/S stopped-ow instrument equipped with a
MOS-250 spectrometer, a temperature controller, and three
10 mL step-motor-driven syringes which can be operated inde-
pendently to carry out single- or double-mixing. For light
scattering detection at a scattering angle q ¼ 90 and at 37.0 C,
both the excitation and emission wavelengths were adjusted to
335 nm with 10 nm slits. Using either FC-08 or FC-15 ow cells,
typical dead times are 1.1 ms and 2.6 ms, respectively. Both the
nanogel dispersions and the glucose solutions were passed
through Millipore Millex-HV lters with a pore size of 0.80 mm
to remove dust before the response kinetics measurements. The
nal concentrations of the nanogels (50.0 mg mL1) and glucose
(50.0 mM to 20.0 mM) were controlled by varying the mixing
ratio of the nanogel dispersion to the glucose solutions. Data
collection commenced 3.0 ms aer activating the pneumatic
drive mechanism of the stopped ow apparatus. Each kinetic
curve reported here represents an average of at least ve
consecutive mixing trials.
Adsorption experiments
Adsorption of dextran and RNase B on the ConA@poly(NIPAM)
nanogels was carried out by mixing dextran and RNase B in a
phosphate buffer solution (PBS) (5.0 mM, pH 7.4) (V ¼ 5.0 mL)
at a given concentration (C0 ¼ 44.0 g L1) to a mass (mnanogels ¼
50.0 mg) of the nanogels in tubes at 37.0 C. Aer being
maintained for 24 h to reach equilibrium, the mixture was
centrifuged (25 C, 10 000 rpm, and 30 min) and washed with
water twice. The dextran/RNase B–nanogel complexes were
collected and redispersed in PBS (5.0 mL) for analyzing the
effect of adsorption of dextran/RNase B on the nanogels (as well
as DLS tests; see above). Moreover, the dextran/RNase B188 | Polym. Chem., 2014, 5, 186–194concentration in the supernatant, CE, was determined using
UV-vis absorption, based on the linear calibration curve
(R2 > 0.99) measured using the solutions with known concen-
trations under the same conditions, for the calculation of
surface density d of the protein:
d ¼ 2hRhiðC0  CEÞVrnanogels
6mnanogels
(1)
where rnanogels and hRhi are the density and hydrodynamic
radius, respectively, of the nanogels. The rnanogels value was
estimated to be 0.01 g cm3 for the swollen nanogels, and
0.08–0.27 g cm3 for the collapsed nanogels.44 For glucose-
dependent tests, the PBS solutions containing different glucose
concentrations were used in the absorption and analyzing
procedures.In vitro insulin uploading and release experiments
Insulin was loaded to the ConA@poly(NIPAM) nanogels by the
complexation method. A fresh solution of insulin (1.0 mg mL1)
was prepared in PBS (5.0 mM, pH 5.1). The pH value of the
nanogels (5.0 mL, [Glu] ¼ 6.0 mM) was adjusted to 5.1 by using
dilute HCl solution. This dispersion was stirred in an ice water
bath for 30 min; insulin solution (1.0 mL) was then added
dropwise to the vial. The immediate clouding revealed the
hydrogen bonding complexation of insulin molecules with the
nanogels. Aer stirring for 3 days, the suspension was centri-
fuged (6000 rpm, 30 min, and 37 C). To remove free drug, the
precipitate was redispersed in PBS (5.0 mL, pH 7.4) and further
puried by repeated centrifugation and washing at 37 C.
Finally, the precipitate was re-dispersed in PBS (1.0 mL, pH 7.4)
for the in vitro release test immediately (see below). All the upper
clear solutions were collected, and the total insulin content was
measured using a Coomassie Plus (Bradford) protein assay by
UV-vis absorption spectrometry at 595 nm. The amount of
loaded insulin in nanogels was calculated from the decrease in
drug concentration. The loading content is expressed as the
mass of loaded drug per unit weight of dried nanogels.
The in vitro release of insulin from the nanogels was evalu-
ated by the dialysis method. A dialysis bag lled with 1.0 mL of a
puried insulin-loaded nanogel dispersion was immersed in
PBS (50.0 mL, pH 7.4) at 37.0 C and at various glucose
concentrations. The released insulin outside of the dialysis bag
was sampled at dened time intervals and measured using a
Coomassie Plus (Bradford) protein assay by UV-vis absorption
spectrometry at 595 nm. The cumulative release is expressed as
the total percentage of drug released through the dialysis
membrane over time. The release experiments were also
performed to show the evolution of the release kinetics in
response to glucose concentration changes.
To evaluate the nanogels’ ability to adapt to cyclical changes
in glucose concentrations, the nanogel sample was rst
incubated in PBS (50.0 mL, pH 7.4) containing 6.0 mM glucose
for 30 min at 37.0 C. At that point, the dialysis bag containing
the sample was taken out. The dialysis bag containing the
sample was washed twice with PBS and then incubated in fresh
PBS (50.0 mL, pH 7.4) containing 15.0 mM glucose for anotherThis journal is © The Royal Society of Chemistry 2014
Fig. 1 (a) Photograph and (b) TEM image of the ConA@poly(NIPAM)
nanogels.
Fig. 2 (a and b) DLS size distribution of (a) the ConA@poly(NIPAM)
nanogels and (b) the uncrosslinked nanogels (serve as a control) before
dialysis. (c and d) DLS size distribution of the ConA@poly(NIPAM)
nanogels before (-) and after (C) (c) 3 days of dialysis or (d) 2 months
of storage at room temperature. All measurements were made in


































View Article Online30 min. This cycle was repeated numerous times. Similarly, the
insulin concentration was determined using the Coomassie
Plus protein assay.
In vitro cytotoxicity
The cytotoxicity tests were carried out by following the method
reported previously by our group.39 Cos-7 cells were plated in
Dulbecco’s modied Eagle medium (DMEM) with 10% fetal calf
serum (FCS) at 1.0  104 cells per well in two 96-well plates and
allowed to grow overnight at 37 C in a 5% CO2 incubator. The
following day, the media were aspirated from the wells and the
cells were treated with various concentrations of nanogels sus-
pended in growing media, using three wells per concentration.
The percentage of DMEM and FCS was kept constant in each
well. The plate was assayed 24 hours aer nanogel addition. To
estimate the amount of cell death, the wells were washed twice
with phosphate-buffered saline, followed by the addition of
120.0 mL of 16.7% CellTiter 96® Aqueous One Solution to cell
culture media in each well and further incubation at 37 C in
5% CO2. Aer 4 hours, three portions of the solution obtained
from each well were transferred to three respective wells of a
96-well plate. Absorbance was measured at 490 nm using a plate
reader. The percentage of live cells was calculated relative to
wells under similar media conditions to the experimental wells
but without any nanogels. The tests on the cytotoxicity of free
ConA were also performed following the same method, but by
simply replacing nanogels with free ConA.
Other characterizations
FTIR spectra were recorded at 37.0 C using a Thermo Electron
Corporation Nicolet 380 Fourier transform infrared spectrom-
eter. TEM images were taken on a JEOL JEM-2100 transmission
electron microscope at an accelerating voltage of 200 kV. The
pH values were measured on a EUTECH PH 700 instruments.
Results and discussion
The ConA@poly(NIPAM) nanogels were prepared by direct poly-
merization of the NIPAM monomers and the crosslinker MBAAm
initiated by APS/TEMED (as a redox initiator system, where the
TEMED catalyses the decomposition of the persulfate ion to give
sulfate free radicals which initiate the polymerization of mono-
mers) in the ConA aqueous solution in the presence of the
surfactant SDS at 40.0 C. The preparation of nearlymonodisperse
poly(NIPAM) nanogels, which has a lower critical solution
temperature around 32 C in water,14 has been well-established
from the precipitation polymerization in water.38–44 NIPAM can
complex with ConA through the hydrogen bonding between the
amide groups of NIPAM and the amino groups of ConA (see
below).57 The polymerization and cross-linking of the NIPAM
monomers that are complexed with ConA can result in narrowly
distributed gel particles with a chemically cross-linked poly-
(NIPAM) network interpenetrated by ConA. At the end of poly-
merization, a light-white colour was observed in the dispersion
(Fig. 1a). The TEM image shown in Fig. 1b displays a typically
spherical shape of the obtained ConA@poly(NIPAM) nanogels.This journal is © The Royal Society of Chemistry 2014Fig. 2a shows the DLS size distribution of the Con-
A@poly(NIPAM) nanogels. A narrow size distribution range
from 26 to 65 nm is observed and the average hydrodynamic
radius (hRhi) is determined to be 46 nm. The nanogels can be
well reproducible from batch to batch, with a high yield of
$92%. Meanwhile, a nanogel (serving as a control) without
chemical cross-linkage was also prepared following the proce-
dures for the synthesis of the presented ConA@poly(NIPAM)
nanogels, except that MBAAm was not added. From Fig. 2b, it
can be seen that the hRhi of uncrosslinked nanogels (605 nm) is
much larger than that of the ConA@poly(NIPAM) nanogels,
suggesting that the cross-linking reaction further solidies and
stabilizes the ConA@poly(NIPAM) nanogels; this is also
supported by the fact that aer dialysis against water, the
opalescent solution was retained for the ConA@poly(NIPAM)
nanogels, while the solution became completely colorless for
uncrosslinked nanogels. The size of the cross-linked nanogels is
tunable. An increase in the feeding amount of the crosslinker
MBAAm (Fig. 3a), or the surfactant SDS (Fig. 3b), in the
synthesis can signicantly reduce the hRhi of the nanogels. All
the cross-linked nanogels showed good stability, with the sizePolym. Chem., 2014, 5, 186–194 | 189
Fig. 3 The hRhi of the nanogels synthesized with different weight
ratios of NIPAM/ConA/MBAAm/SDS. To show the effect of the feeding
amount of (a) MBAAm and (b) SDS, the feeding amounts of NIPAM and
ConA were set to 1.200 g and 0.036 g, respectively. All measurements


































View Article Onlinedistribution being nearly the same before and aer dialysis
(Fig. 2c; also see below), or even before and aer 2 months of
storage at room temperature (Fig. 2d). The good stability of the
chemically cross-linked nanogels is a key parameter in the
following characterization of the responsive volume phase
transition, as well as their potential use in regulating the
diffusion and releasing of the trapped drug molecules.
FTIR spectroscopy was used to conrm the structure of the
puried ConA@poly(NIPAM) nanogels. In FTIR spectra (Fig. 4a,
and S1 in the ESI; also see Fig. S2 in the ESI† for FTIR spectra of
ConA and NIPAM), the characteristic bands of the carbonyl
stretching vibration (amide I) at 1658 cm1 and N–H bending
vibration (amide II) at 1547 cm1, as well as two typical bands of
C–H vibrations of –CH(CH3)2 at 1385 cm
1 and 1367 cm1, of
NIPAM units were recorded. Aer interpenetration by ConA, the
nanogels display additional characteristic amide I bands of ConA
at 1650 cm1 and 1634 cm1, which are consistent with the
bands for a b-structure of ConA.55 FTIR analysis also conrmed
the strong hydrogen bonding between the amide groups of
NIPAM and the amino groups of ConA with a blue-shi of the
N–H stretching vibration band at 3407 cm1, in comparison with
those of pure ConA (3385 cm1) and NIPAM (3303 cm1).
It is known that ConA can bind glucose with the D-arabino
conguration at carbons 3, 4 and 5 and unmodied hydroxyl
groups at carbons 3, 4 and 6.55 Fig. 4a compares the FTIR spectra
of the ConA@poly(NIPAM) nanogels in the absence (with the
glucose concentration [Glu]¼ 0.0mM) and the presence ([Glu]¼
20.0 mM) of glucose. Upon adding glucose, one can observe a
decrease in the width of the amide I bands of ConA, and anFig. 4 (a) FTIR spectra of the ConA@poly(NIPAM) nanogels in the
absence (0.0 mM) and presence (20.0 mM) of glucose, and (b) the
same spectra after resolution enhancement by deconvolution.
190 | Polym. Chem., 2014, 5, 186–194apparent displacement of the whole bands toward lower wave-
numbers. Details of these changes are clearly revealed by the
deconvolution spectra in Fig. 4b, which shows that there is no
change in the position of the amide I band of NIPAM units at
1658 cm1; however, the major amide I band of ConA at
1650 cm1 shis to 1642 cm1, as well as the red-shi of
1634 cm1 to 1624 cm1. The spectral changes were also
conrmed by the derivation spectra of enhanced resolution
(Fig. S3 in the ESI†). Similar phenomena on the red-shi of the
amide I band have been found on the apo-ConA upon deme-
tallization.58 It is reported that the small spectral changes in the
amide I band cannot represent major changes in the secondary
structure, however, they are sufficient to suggest a general
“loosening” of the tightly packed structure with some rear-
rangement of the hydrogen bonding.58,59 The small spectral
change in our cases may thus imply a volume change of the
involved ConA@poly(NIPAM) nanogels. We then examined the
effect of the concentration of glucose on the ConA@poly(NIPAM)
nanogels by using DLS, which is a powerful tool to in situ study
volume phase transition behaviour of polymer gel particles in
solutions. Fig. 5a shows the DLS intensity autocorrelation
functions (C(s)) for the ConA@poly(NIPAM) nanogels dispersed
in solutions with different glucose concentrations of [Glu]¼ 0.0,
3.0, and 20.0 mM. In the absence of glucose ([Glu] ¼ 0.0 mM),
the diffusion coefficient (D) was 1.9  107 cm2 s1, corre-
sponding to a hRhi of 46 nm (Fig. 5b); interestingly, increasing
the [Glu] to 3.0 mM and 20.0 mM decreased D to 1.0  107 cm2
s1 and 5.2  108 cm2 s1, respectively, indicating an increase
in the hRhi to 77 nm and 128 nm correspondingly. The increasedFig. 5 (a) DLS intensity autocorrelation functions (C(s)) and (b) size
distribution for the ConA@poly(NIPAM) nanogels dispersed in
solutions with glucose concentrations [Glu] ¼ 0.0 (-,,), 3.0 (C, B),
and 20.0 mM (:, O). Closed and open symbols denote the size
distribution before and after ten cycles of adding/removing glucose,
respectively. (c) Swelling and recovery cycles upon the repeated
addition (20.0 mM) and dialysis removal of glucose (0.0 mM) in the
dispersion medium of the nanogels. (d) Glucose-dependent hRhi
values. Closed and open symbols denote the adding and removing
glucose cycles, respectively. All measurements were made in 5.0 mM
PBS of pH ¼ 7.4 at 37.0 C.


































View Article OnlinehRhi at the higher [Glu] veried the swelling of the nanogels
upon adding glucose. The swelling ratio, in terms of hRhi20.0 mM/
hRhi0.0 mM, is determined to be 2.8. Since the complexes between
ConA and glucose molecules appear to involve charge–dipole
and hydrogen-bond interactions, these non-covalent complexing
manners should make the association/dissociation fully revers-
ible.55 As glucose is removed from the bathing medium by
dialysis against very frequently changed water, the breakage of
the ConA–glucose non-covalent bond complexes occurs, leading
to a full recovery of the hRhi (99–102% of the original basal value)
within the experimental error even aer ten cycles of adding and
removing glucose (Fig. 5b and c). A detailed study further indi-
cates that the swelling/shrinking processes of the nanogels upon
adding/removing glucose can elegantly occur over a clinically
relevant range (0–20 mM) at a physiological pH of 7.4 (Fig. 5d).
The reversibility of the glucose-responsive volume phase tran-
sition is clearly demonstrated by the perfect match of the adding
and removing glucose curves, as well as the repeatable size
distribution during adding/removing glucose cycles. Therefore,
these results can not only provide direct proof for the glucose-
responsive volume change of the ConA@poly(NIPAM) nanogels,
but also foreshadow a novel class of glucose-responsive
nanogels.
To estimate the response time of the glucose-responsive
volume phase transition that is potentially achievable, we have
monitored the response kinetics based on the scattered light
intensity (I) change of the ConA@poly(NIPAM) nanogel disper-
sions aer adding different concentrations of glucose. As shown
in Fig. 6a, upon adding glucose, the relative scattered light
intensity (It/I0, where It is the scattered light intensity at a certain
time t, and I0 at t ¼ 3.0 ms aer mixing) of the nanogel disper-
sions increased immediately and then leveled off gradually. The
It/I0 became stable shortly (<1 s) aer the addition of glucose
over a glucose concentration range 50.0 mM to 20.0 mM. The
higher the glucose concentration, the faster the kinetics of the
glucose-response. For example, when [Glu] ¼ 20.0 mM, the It/I0
can become stable within 0.2 s. Assuming the glucose-responsive
volume phase transition of the nanogels and the corresponding
scattering light variation follow the rst order kinetics,60 the
apparent rate constants (k) can be derived from the tting of the
time dependent It/I0 (Fig. S4 in the ESI†). The k was thus deter-
mined to be ca. 41.2 s1 at [Glu] ¼ 20.0 mM. The linear tting of
the k–[Glu] plot (Fig. 6b) results in the association rate constantFig. 6 (a) Variation in the It/I0 for the ConA@poly(NIPAM) nanogels
upon adding glucose. (b) A plot of k–[Glu]. The final concentration of
the nanogel was fixed at 50.0 mg mL1. All measurements were made
in 5.0 mM PBS of pH ¼ 7.4 at 37.0 C.
This journal is © The Royal Society of Chemistry 2014k1 of ca. 1.8mM
1 s1 (obtained from the slope of the linear plot)
and the dissociation rate constant k2 of ca. 7.5 s
1 (obtained
from the intercept), indicating a fast reversible time response to
the glucose concentration change of the nanogels. In this
important feature lies the great potential of the nanogels for
continuous glucose monitoring related applications.
We now turn our attention to the potential response of the
ConA@poly(NIPAM) nanogels to some other monosaccharides,
such as fructose, mannose, and galactose, which are naturally
occurring typical stereoisomers of glucose. As shown in Fig. 7a,
the nanogels gave a neglectable change in the overall response
to galactose, due to the fact that the Con A chains show no
affinity towards the galactose molecule because of the destruc-
tion of 4-OH.55 In contrast, the swelling process of the nanogels
upon adding fructose or mannose can elegantly occur over the
investigated concentration window (0–20 mM), due to the high
affinity of the ConA to the D-arabino conguration of these
monosaccharides.46 The swelling ratio, hRhi20.0 mM/hRhi0.0 mM,
was found to be 3.0 and 3.3 for the addition of fructose and
mannose, respectively, demonstrating amuch higher sensitivity
of the nanogels to mannose over fructose, and over glucose. It is
thus probable that fructose and mannose would be the primary
interferences if the nanogels were used as glucose-responsive
materials in bio-systems. Fig. 7b shows the impact of a range of
fructose and mannose concentrations (50.0 mM to 1.0 mM) on
the glucose-responsive volume phase transition of the nanogels.
The competitive binding of fructose or mannose to the ConA in
the nanogels reduces the glucose binding degree, thus
decreases the sensitivity of the nanogels in response to glucose.
The deviations become more pronounced at the higher fructose
or mannose concentrations. However, since the physiological
level of fructose and mannose in the blood of all mammals is
#0.1 mM,61 the data in Fig. 7b indicate that the nanogels
serving as glucose-responsive materials should be free from
signicant interferences of fructose and mannose, as there was
<2% variation in the glucose-responsive volume change in the
presence of 0.1 mM fructose or mannose.
Besides monosaccharides, we also checked the binding of
the ConA@poly(NIPAM) nanogels to dextran (Mr  6000),
dextran (Mr  40 000), dextran (Mr  100 000), and RNase B,Fig. 7 (a) The hRhi of the ConA@poly(NIPAM) nanogels as a function of
the concentration of fructose (,), galactose (B), and mannose (O).
(b) Glucose-dependent hRhi values of the nanogels in the absence
(spherical symbols) and presence of fructose (solid symbols) or
mannose (open symbols) at different concentrations (-, ,: 50.0 mM;
C, B: 0.1 mM; :, O: 1.0 mM). All measurements were made in 5.0
mM PBS of pH ¼ 7.4 at 37.0 C.
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Fig. 8 (a) Isothermal adsorption curves for dextran (Mr  6000) (,),
dextran (Mr  40 000) (B), dextran (Mr  100 000) (O) and RNase B
(>) adsorbed onto the ConA@poly(NIPAM) nanogels. (b) Glucose-
dependent hRhi values of the nanogels in the absence (spherical
symbols) and presence of adsorbed dextran (Mr  6000) (,), dextran
(Mr  40 000) (B), dextran (Mr  100 000) (O) and RNase B (>).
Fig. 9 (a) Releasing profiles of insulin from the ConA@poly(NIPAM)
nanogels in the presence of 0.0 mM (-), 6.0 mM (C), 8.0 mM (:),
10.0 mM (;), 15.0 mM (=), and 20.0 mM (<) glucose in PBS of 7.4 at
37 C. In the blank release (>), the insulin solution was released to the
PBS. (b) The self-regulated profile of the nanogels presents the rate of
insulin release as a function of glucose concentration. Data points


































View Article Onlinesince those polysaccharides/glycoproteins also contain glycosyl
or mannosyl residues of the D-arabino conguration. Fig. 8a
shows that dextran and RNase B can indeed adsorb onto the
nanogels, whereas only a low adsorption level was recorded
(with the surface density d < 0.04 g m2). Dextran and RNase B
are relatively large molecules. It is possible that they would only
bind the ConA located at the light penetration depth of the
nanogels, and the initial binding of dextran or RNase B would
subsequently hinder the accessibility of ConA to more dextran
or RNase B molecules. Thus it is unlikely that those poly-
saccharides/glycoproteins will interfere signicantly with the
glucose-response of the nanogels. The low level adsorption of
dextran and RNase B to the nanogels only caused a slightly
larger glucose-responsive swelling degree (Fig. 8b; <103% of the
hRhi values of the nanogels in the absence of any dextran or
RNase B).
Having demonstrated the reversible and rapid glucose-
response of the ConA@poly(NIPAM) nanogels with minimal
interferences from common non-glucose constituents, we
nally tested the insulin loading and release performance with
those nanogels as carriers in view of their potential biomedical
applications. Giving that the ConA@poly(NIPAM) nanogels
might only have a low level adsorption of insulin if insulin was
loaded to the nanogels by the same adsorption method as that
of dextran/RNase B, two arrangements have been made to the
uploading procedures of insulin so as to enhance the drug
loading capability. Firstly, insulin was loaded to the permeable
mesh of the nanogel particle by co-incubation at a low
temperature of 4 C (rendering a swollen status of the nano-
gels; see Fig. S5 in the ESI†) for a prolonged time of 3 days.39
Secondly, the pH value (pH ¼ 5.1) of the co-incubation medium
was adjusted to around the isoelectric point (pH ¼ 5.0–5.3)16 of
insulin, so as to enhance the hydrogen bonding between the
amide groups of poly(NIPAM) and the carboxylate groups of
insulin,31,39 whilst decreasing the electrostatic repulsion either
among the deprotonated carboxylate groups (at pH > pI) or the
protonated amine groups (at pH < pI) of insulin. Moreover, at
pH z pI, the insulin molecule adopts a relatively compact
structure,25 which should also favour the diffusion of the insulin
molecule into the expanded mesh of the nanogel particle. Aer
the co-incubation, the insulin-loaded nanogels were puried at
37 C (rendering a collapsed status of the nanogels; see Fig. 5d192 | Polym. Chem., 2014, 5, 186–194and S5 in the ESI†) and pH ¼ 7.4 (reducing the hydrogen
bonding between the amide groups of poly(NIPAM) and the
carboxylate groups of insulin), to ensure the encapsulation of
the insulin molecule within the nanogel particle mainly via a
physical restriction effect of the polymer network. The yield of
insulin loaded into the nanogels was determined to be ca.
39.8 wt% (expressed as the mass of loaded drug per unit weight
of dried nanogels), i.e., ca. 10.3 IU mg1 nanogels. Considering
the approximate concentration of the nanogel dispersions, this
insulin loading capability is equivalent to ca. 403.8 IU L1. It
should be noted that the insulin-loaded nanogels can be
concentrated and adjusted to an appropriate concentration to
cover an even higher dose.
Since the diffusion of the physically encapsulated molecules
through a gel network is dependent on the changes inmesh size
caused by the volume phase transition of the gel,25,62 the Con-
A@poly(NIPAM) nanogels should be effective in bringing about
a controlled release. Fig. 9a shows the in vitro insulin releasing
proles from the preloaded nanogels measured by the dialysis
method in pH ¼ 7.4 PBS at 37.0 C. A blank release experiment
of free insulin (5807.69 daltons) solution with an equivalent
amount of drug to that encapsulated in the nanogels was also
performed, showing that the dialysis membrane (cutoff 12 000–
14 000 daltons) played a negligible role in the release kinetics.
Accumulated insulin release studies were performed and
limited insulin release from the nanogels was observed within 2
days of incubation at a normal glucose concentration (6.0 mM)
and glucose-free PBS. In contrast, faster insulin release was
achieved from the nanogels under the hyperglycemic environ-
ments ($7.0 mM), and the release can be regulated by varying
the glucose concentration in the releasing medium. The time
scales for insulin delivery are compatible with the patient’s
needs, since the nanogels could deliver insulin in less than 30
min, and the sustained release over 2 days may also meet the
basal needs.26 Furthermore, the insulin release prole of
nanogels presented a pulsatile pattern when the glucose
concentration was cyclically varied between a normal (6.0 mM)
and a hyperglycemic concentration (15.0 mM) every 30 min for
several repetitions (Fig. 9b). The nanogels responded to the
changes in glucose concentration, and a maximum ca. 10-fold
increase in the insulin release rate was obtained when theThis journal is © The Royal Society of Chemistry 2014
Fig. 10 In vitro cytotoxicity of the ConA@poly(NIPAM) nanogels and


































View Article Onlineglucose concentration was switched to the hyperglycemic
concentration. Collectively, these results point to the volume
phase transition of the nanogels and the subsequent insulin
release is a glucose-responsive process. Although the current
results are obtained from in vitro studies, their characteristics
for self-regulated insulin delivery could be extremely important
in the treatment of diseases.
For future biomedical applications, the nanogels as carriers
should be non- or low-cytotoxic. Assuming a required delivery of 24
IU per day, the therapeutic amount of our ConA@poly(NIPAM)
nanogels need only be 4.8–16.0 mg aer taking account of the
release amount. A typical adult has a blood volume between 4.7
and 5.0 L, with females generally having a smaller blood volume
thanmales.61 That is, the concentration of the nanogels used in the
blood stream could be less than 3.4 mg mL1. As shown in Fig. 10,
the ConA@poly(NIPAM) nanogels showed non- or low-cytotoxicity
to Cos-7 cells aer incubation for 24 h at concentrations of up to
20.0 mg mL1. Considering the possibility of degradation of the
polymer gels during the long circulation, the potential cytotoxicity
of free ConA was also addressed. Once again, free ConA exhibited
low cytotoxicity at all the studied concentrations.Conclusion
A novel class of glucose-responsive nanogels with ConA inter-
penetrated in a chemically crosslinked poly(NIPAM) network
can be successfully synthesized from the precipitation poly-
merization of NIPAM monomers in ConA aqueous solution at a
low temperature of 40.0 C. The increase in the feeding amount
of the crosslinker MBAAm, or the surfactant SDS, in the
synthesis can signicantly reduce the hRhi of the nanogels. All
those nanogels showed good stability. The newly developed
semi-interpenetrating-structured nanogels can undergo a
reversible and rapid volume phase transition in response to the
disruptions in the homeostasis of glucose concentration at
physiological pH and temperature. While the nanogels can
swell and become stable shortly (<1 s) aer adding glucose over
a glucose concentration range of 50.0 mM to 20.0 mM, theThis journal is © The Royal Society of Chemistry 2014changes in the hRhi and the size distribution of the nanogels can
be fully reversible within the experimental error even aer ten
cycles of adding/removing glucose. The association rate
constant is determined to be ca. 1.8 mM1 s1, and the disso-
ciation rate constant is ca. 7.5 s1, indicating a fast reversible
time response to the glucose concentration change of the
nanogels. While the porous network structure of the nanogels
can provide high insulin loading capacity, the reversible and
rapid volume change of the nanogels as a function of media
glucose concentration can regulate the drug release and thereby
can enable a self-regulated strategy for insulin delivery. Such a
novel class of glucose-responsive nanogels may nd important
biomedical applications.Acknowledgements
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